Miles Kocur Huseyin

Miles Kocur Huseyin

Auto-generated profile, based on publicly available information

Miles Kocur Huseyin

Department of Biological Engineering, Massachusetts Institute of Technology; Cambridge, MA 02139, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2023 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
VGViraat Y. Goel
Viraat Y. Goel
MHMiles K. Huseyin
Miles K. Huseyin
AHAnders S. Hansen
Anders S. Hansen

27 June 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
ADAndreas Diepold
Andreas Diepold
Erdinc SezginErdinc Sezgin
Erdinc Sezgin
MHMiles Huseyin
Miles Huseyin
TMThomas Mortimer
Thomas Mortimer
CEChristian Eggeling
Christian Eggeling
JAJudith P Armitage
Judith P Armitage
Many bacteria use a type III secretion system (T3SS) to inject effector proteins into host cells. Selection and export of the effectors is controlled by a set of soluble proteins at the cytosolic interface of the membrane spanning type III secretion ‘injectisome’. Combining fluorescence microscopy, biochemical interaction studies and fluorescence correlation spectroscopy, we show that in live Yersinia enterocolitica bacteria these soluble proteins form complexes both at the injectisome and in the cytosol. Binding to the injectisome stabilizes these cytosolic complexes, whereas the free cytosolic complexes, which include the type III secretion ATPase, constitute a highly dynamic and adaptive network. The extracellular calcium concentration, which triggers activation of the T3SS, directly influences the cytosolic complexes, possibly through the essential component SctK/YscK, revealing a potential mechanism involved in the regulation of type III secretion.

22 April 2021 in Genes & Development
Verified
Journal Article
Open access
PDF file
NFNadezda A. Fursova
Nadezda A. Fursova
ATAnne H. Turberfield
Anne H. Turberfield
NBNeil P. Blackledge
Neil P. Blackledge
EFEmma L. Findlater
Emma L. Findlater
ALAnna Lastuvkova
Anna Lastuvkova
RKRobert J. Klose
Robert J. Klose
Histone-modifying systems play fundamental roles in gene regulation and the development of multicellular organisms. Histone modifications that are enriched at gene regulatory elements have been heavily studied, but the function of modifications found more broadly throughout the genome remains poorly understood. This is exemplified by histone H2A monoubiquitylation (H2AK119ub1), which is enriched at Polycomb-repressed gene promoters but also covers the genome at lower levels. Here, using inducible genetic perturbations and quantitative genomics, we found that the BAP1 deubiquitylase plays an essential role in constraining H2AK119ub1 throughout the genome. Removal of BAP1 leads to pervasive genome-wide accumulation of H2AK119ub1, which causes widespread reductions in gene expression. We show that elevated H2AK119ub1 preferentially counteracts Ser5 phosphorylation on the C-terminal domain of RNA polymerase II at gene regulatory elements and causes reductions in transcription and transcription-associated histone modifications. Furthermore, failure to constrain pervasive H2AK119ub1 compromises Polycomb complex occupancy at a subset of Polycomb target genes, which leads to their derepression, providing a potential molecular rationale for why the BAP1 ortholog in Drosophila has been characterized as a Polycomb group gene. Together, these observations reveal that the transcriptional potential of the genome can be modulated by regulating the levels of a pervasive histone modification.

9 February 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
MHMiles K. Huseyin
Miles K. Huseyin
RKRobert J. Klose
Robert J. Klose
Polycomb repressive complex 1 (PRC1) is an essential chromatin-based repressor of gene transcription. How PRC1 engages with chromatin to identify its target genes and achieve gene repression remains poorly defined, representing a major hurdle to our understanding of Polycomb system function. Here, we use genome engineering and single particle tracking to dissect how PRC1 binds to chromatin in live mouse embryonic stem cells. We observe that PRC1 is highly dynamic, with only a small fraction stably interacting with chromatin. By integrating subunit-specific dynamics, chromatin binding, and abundance measurements, we discover that PRC1 exhibits low occupancy at target sites. Furthermore, we employ perturbation approaches to uncover how specific components of PRC1 define its kinetics and chromatin binding. Together, these discoveries provide a quantitative understanding of chromatin binding by PRC1 in live cells, suggesting that chromatin modification, as opposed to PRC1 complex occupancy, is central to gene repression.

3 April 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
SWSina Wittmann
Sina Wittmann
MRMax Renner
Max Renner
BWBeth R. Watts
Beth R. Watts
OAOliver Adams
Oliver Adams
MHMiles Huseyin
Miles Huseyin
LVLidia Vasiljeva
Lidia Vasiljeva
Termination of RNA polymerase II (Pol II) transcription is an important step in the transcription cycle, which involves the dislodgement of polymerase from DNA, leading to release of a functional transcript. Recent studies have identified the key players required for this process and showed that a common feature of these proteins is a conserved domain that interacts with the phosphorylated C-terminus of Pol II (CTD-interacting domain, CID). However, the mechanism by which transcription termination is achieved is not understood. Using genome-wide methods, here we show that the fission yeast CID-protein Seb1 is essential for termination of protein-coding and non-coding genes through interaction with S2-phosphorylated Pol II and nascent RNA. Furthermore, we present the crystal structures of the Seb1 CTD- and RNA-binding modules. Unexpectedly, the latter reveals an intertwined two-domain arrangement of a canonical RRM and second domain. These results provide important insights into the mechanism underlying eukaryotic transcription termination.

20 February 2015 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HLHarshani R. Lawrence
Harshani R. Lawrence
KMKiran Mahajan
Kiran Mahajan
YLYunting Luo
Yunting Luo
DZDaniel Zhang
Daniel Zhang
NTNathan Tindall
Nathan Tindall
NLNicholas J. Lawrence
Nicholas J. Lawrence